Multinational pharmaceutical firms to benefit from China guidelines: analysts
- Posted on April 22, 2026
- By South China Morning Post
- 0 Views
- 1 min read
Multinational pharmaceutical firms to benefit from China guidelines: analysts
Document demonstrates government’s ‘commitment to fostering a robust and globally competitive domestic pharmaceutical industry’.
